MedTrace Logo

Evaluation of the Efficacy and Safety of PiQo4 System for the Treatment of Pigmented Lesions

NCT03565146 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2019-12-27

No results posted yet for this study

Summary

A total of at least 25 healthy subjects at a single site, aged 21-70 years old with congenital or acquired challenging/resistant, age/sun-related flat and benign facial pigmentation with or without hand pigmentation who wish to improve their skin appearance.

Conditions

  • Pigmentation

Interventions

DEVICE

PiQo4 Laser System

PiQo4 Laser System for treatment of pigmented lesions

Sponsors & Collaborators

  • Focus Medical, LLC

    lead INDUSTRY

Principal Investigators

  • Daniel P Friedmann · Westlake Dermatology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-29
Primary Completion
2019-06-05
Completion
2019-06-05
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03565146 on ClinicalTrials.gov